Pharmacological treatment for familial amyloid polyneuropathy

BACKGROUND: Disease‐modifying pharmacological agents for transthyretin (TTR)‐related familial amyloid polyneuropathy (FAP) have become available in the last decade, but evidence on their efficacy and safety is limited. This review focuses on disease‐modifying pharmacological treatment for TTR‐relate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Magrinelli, Francesca, Fabrizi, Gian Maria, Santoro, Lucio, Manganelli, Fiore, Zanette, Giampietro, Cavallaro, Tiziana, Tamburin, Stefano
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2020
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170468/
https://ncbi.nlm.nih.gov/pubmed/32311072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012395.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi